Bringing you the latest from Medical Developments International
MDI (MVP:ASX) FY23 Full Year Results Investor Presentation
Green whistle gets the green light for preparation of US clinical trial
MDI awarded up to $1.5M in funding for next generation device for acute pain
FY23 Half Year ASX Announcement
MDI (MVP:ASX) FY22 Half Year Results Investor Presentation
Company Chair and CEO Address to Shareholders
MAT-AU-BAT-WB-0014